These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26088114)

  • 1. Borderline Personality Disorder and Oxytocin: Review of Clinical Trials and Future Directions.
    Amad A; Thomas P; Perez-Rodriguez MM
    Curr Pharm Des; 2015; 21(23):3311-6. PubMed ID: 26088114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the role of oxytocin in borderline personality disorder.
    Brüne M
    Br J Clin Psychol; 2016 Sep; 55(3):287-304. PubMed ID: 26616386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intranasal oxytocin administration on empathy and approach motivation in women with borderline personality disorder: a randomized controlled trial.
    Domes G; Ower N; von Dawans B; Spengler FB; Dziobek I; Bohus M; Matthies S; Philipsen A; Heinrichs M
    Transl Psychiatry; 2019 Dec; 9(1):328. PubMed ID: 31801937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxytocin can hinder trust and cooperation in borderline personality disorder.
    Bartz J; Simeon D; Hamilton H; Kim S; Crystal S; Braun A; Vicens V; Hollander E
    Soc Cogn Affect Neurosci; 2011 Oct; 6(5):556-63. PubMed ID: 21115541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxytocin and Borderline Personality Disorder.
    Bertsch K; Herpertz SC
    Curr Top Behav Neurosci; 2018; 35():499-514. PubMed ID: 28812272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-Analysis.
    Gartlehner G; Crotty K; Kennedy S; Edlund MJ; Ali R; Siddiqui M; Fortman R; Wines R; Persad E; Viswanathan M
    CNS Drugs; 2021 Oct; 35(10):1053-1067. PubMed ID: 34495494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxytocin influences avoidant reactions to social threat in adults with borderline personality disorder.
    Brüne M; Ebert A; Kolb M; Tas C; Edel MA; Roser P
    Hum Psychopharmacol; 2013 Nov; 28(6):552-61. PubMed ID: 23950057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of oxytocin on social cognition in borderline personality disorder.
    Servan A; Brunelin J; Poulet E
    Encephale; 2018 Feb; 44(1):46-51. PubMed ID: 29273344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of interpersonal trust in borderline personality disorder by intranasal oxytocin and childhood trauma.
    Ebert A; Kolb M; Heller J; Edel MA; Roser P; Brüne M
    Soc Neurosci; 2013; 8(4):305-13. PubMed ID: 23802121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurobiology of social deficits in female patients with borderline personality disorder: The importance of oxytocin.
    Bomann AC; Jørgensen MB; Bo S; Nielsen M; Gede LB; Elfving B; Simonsen E
    Personal Ment Health; 2017 May; 11(2):91-100. PubMed ID: 28397403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopharmacological treatment of patients with borderline personality disorder: comparing data from routine clinical care with recommended guidelines.
    Riffer F; Farkas M; Streibl L; Kaiser E; Sprung M
    Int J Psychiatry Clin Pract; 2019 Sep; 23(3):178-188. PubMed ID: 31140337
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mental health service utilization among borderline personality disorder patients inpatient].
    Cailhol L; Thalamas C; Garrido C; Birmes P; Lapeyre-Mestre M
    Encephale; 2015 Apr; 41(2):115-22. PubMed ID: 25526809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of Psychotropic Drug Therapy in Borderline Personality Disorder: a Case Report.
    Bradford R; Holt C
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S371-4. PubMed ID: 26417798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The process of managing medications in patients with borderline personality disorder.
    Silk KR
    J Psychiatr Pract; 2011 Sep; 17(5):311-9. PubMed ID: 21926526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring nonverbal synchrony in borderline personality disorder: A double-blind placebo-controlled study using oxytocin.
    Ramseyer F; Ebert A; Roser P; Edel MA; Tschacher W; Brüne M
    Br J Clin Psychol; 2020 Jun; 59(2):186-207. PubMed ID: 31774581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonverbal communication of patients with borderline personality disorder during clinical interviews: a double-blind placebo-controlled study using intranasal oxytocin.
    Brüne M; Kolb M; Ebert A; Roser P; Edel MA
    J Nerv Ment Dis; 2015 Feb; 203(2):107-11. PubMed ID: 25594788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxytocin and reduction of social threat hypersensitivity in women with borderline personality disorder.
    Bertsch K; Gamer M; Schmidt B; Schmidinger I; Walther S; Kästel T; Schnell K; Büchel C; Domes G; Herpertz SC
    Am J Psychiatry; 2013 Oct; 170(10):1169-77. PubMed ID: 23982273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased oxytocin plasma levels and oxytocin receptor expression in borderline personality disorder.
    Carrasco JL; Buenache E; MacDowell KS; De la Vega I; López-Villatoro JM; Moreno B; Díaz-Marsá M; Leza JC
    Acta Psychiatr Scand; 2020 Oct; 142(4):319-325. PubMed ID: 32740913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal oxytocin as an adjunct treatment among patients with severe major depression with and without comorbid borderline personality disorder.
    Maoz H; Grossman-Giron A; Sedoff O; Nitzan U; Kashua H; Yarmishin M; Arad O; Tzur Bitan D
    J Affect Disord; 2024 Feb; 347():39-44. PubMed ID: 37992767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological treatment of borderline personality disorder: a retrospective observational study at inpatient unit in Italy.
    Paolini E; Mezzetti FA; Pierri F; Moretti P
    Int J Psychiatry Clin Pract; 2017 Mar; 21(1):75-79. PubMed ID: 27669762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.